CD4 ligand IL-16 inhibits the mixed lymphocyte reaction

Area of Science:

• Immunology
• Cellular Biology
• Molecular Signaling

Background:

• CD4 receptor interaction with MHC class II antigens promotes T cell activation.
• Binding of CD4 to alternative ligands like HIV-1 gp120 or anti-CD4 antibodies inhibits T cell receptor signaling, inducing unresponsiveness.

Purpose of the Study:

• To investigate whether the natural CD4 ligand, interleukin-16 (IL-16), also induces T cell unresponsiveness.
• To elucidate the mechanism by which IL-16 affects T cell proliferation and signaling.

Main Methods:

• Mixed lymphocyte reactions were used to assess T cell proliferation.
• Recombinant IL-16 (rIL-16) was added at varying concentrations to evaluate its suppressive effects.
• Flow cytometry was used to assess CD4 and IL-2 receptor expression.
• T cell viability and basal proliferation were measured.

Main Results:

• rIL-16 suppressed T cell proliferation in a dose-dependent manner.
• The suppressive effect was observed between days 5 and 9 of the mixed lymphocyte reaction.
• rIL-16 did not alter CD4 expression, basal proliferation, or viability.
• Neutralizing anti-rIL-16 monoclonal antibodies or soluble CD4 blocked the suppressive effect.
• IL-2 receptor expression remained unaffected, and exogenous IL-2 did not restore proliferation, suggesting a disruption in IL-2 receptor signaling.

Conclusions:

• IL-16 acts as an inhibitory CD4 ligand, suppressing T cell proliferation.
• The mechanism of IL-16-induced unresponsiveness involves an interruption in IL-2 receptor signaling, distinct from other CD4 ligands.
• These findings provide insights into the dual role of CD4 in signal transduction and the regulatory function of IL-16 in immune responses.